Literature DB >> 34432287

Computational and Bioinformatics Methods for MicroRNA Gene Prediction.

Ege Riza Karagur1,2, Sakir Akgun3, Hakan Akca4.   

Abstract

MicroRNAs (miRNAs) are 20-24-nucleotide-long noncoding RNAs that bind to the untranslated region (3' UTR) of their target mRNAs. The importance of miRNAs in medicine has grown rapidly in the 20 years since the discovery of them. As the regulatory function of miRNAs on biological processes was discovered, they were advocated to play a role in the underlying mechanisms of human pathogenesis. Functional studies have confirmed that miRNAs are promising in preclinical development through deregulation of genes targeted by miRNAs in many cancer cases. In this chapter, we summarize the miRNAs identified for some specific types of cancer and their functions. Besides, miRNAs function as cancer biomarker and their benefits to diagnosis and treatment of cancer are also discussed.
© 2022. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Biomarkers; Cancer; Circulating miRNAs; Exosome; microRNAs

Mesh:

Substances:

Year:  2022        PMID: 34432287     DOI: 10.1007/978-1-0716-1170-8_17

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  83 in total

Review 1.  miRNAs as Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer: Current Perspectives.

Authors:  Mateusz Florczuk; Adam Szpechcinski; Joanna Chorostowska-Wynimko
Journal:  Target Oncol       Date:  2017-04       Impact factor: 4.493

Review 2.  microRNAs as oncogenes and tumor suppressors.

Authors:  Baohong Zhang; Xiaoping Pan; George P Cobb; Todd A Anderson
Journal:  Dev Biol       Date:  2006-08-16       Impact factor: 3.582

Review 3.  MicroRNA functional network in pancreatic cancer: from biology to biomarkers of disease.

Authors:  Jin Wang; Subrata Sen
Journal:  J Biosci       Date:  2011-08       Impact factor: 1.826

4.  The microRNA spectrum in 12 body fluids.

Authors:  Jessica A Weber; David H Baxter; Shile Zhang; David Y Huang; Kuo How Huang; Ming Jen Lee; David J Galas; Kai Wang
Journal:  Clin Chem       Date:  2010-09-16       Impact factor: 8.327

5.  The failure of protein cancer biomarkers to reach the clinic: why, and what can be done to address the problem?

Authors:  Eleftherios P Diamandis
Journal:  BMC Med       Date:  2012-08-09       Impact factor: 8.775

6.  MicroRNAs - Important Molecules in Lung Cancer Research.

Authors:  Petra Leidinger; Andreas Keller; Eckart Meese
Journal:  Front Genet       Date:  2012-01-23       Impact factor: 4.599

Review 7.  Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review.

Authors:  R D Neal; P Tharmanathan; B France; N U Din; S Cotton; J Fallon-Ferguson; W Hamilton; A Hendry; M Hendry; R Lewis; U Macleod; E D Mitchell; M Pickett; T Rai; K Shaw; N Stuart; M L Tørring; C Wilkinson; B Williams; N Williams; J Emery
Journal:  Br J Cancer       Date:  2015-03-31       Impact factor: 7.640

Review 8.  The Tumor Cytosol miRNAs, Fluid miRNAs, and Exosome miRNAs in Lung Cancer.

Authors:  Xin Qin; Haisheng Xu; Wenrong Gong; Wenbin Deng
Journal:  Front Oncol       Date:  2015-01-05       Impact factor: 6.244

Review 9.  Circulating microRNA biomarkers for lung cancer detection in Western populations.

Authors:  Haixin Yu; Zhong Guan; Katarina Cuk; Hermann Brenner; Yan Zhang
Journal:  Cancer Med       Date:  2018-09-27       Impact factor: 4.452

10.  MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma.

Authors:  Charles H Lawrie; Shamit Soneji; Teresa Marafioti; Christopher D O Cooper; Stefano Palazzo; Jennifer C Paterson; Helen Cattan; Tariq Enver; Rachel Mager; Jacqueline Boultwood; James S Wainscoat; Christian S R Hatton
Journal:  Int J Cancer       Date:  2007-09-01       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.